Page last updated: 2024-08-18

4-butyrolactone and Squamous Cell Carcinoma of Head and Neck

4-butyrolactone has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chung, JG; Hsu, SC; Huang, YP; Kuo, YH; Lin, ML; Yu, CC; Yu, FS1

Other Studies

1 other study(ies) available for 4-butyrolactone and Squamous Cell Carcinoma of Head and Neck

ArticleYear
4-Hydroxybutenolide impairs cell migration, and invasion of human oral cancer SCC-4 cells via the inhibition of NF-κB and MAPK signaling pathways.
    International journal of oncology, 2016, Volume: 49, Issue:2

    Topics: 4-Butyrolactone; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Head and Neck Neoplasms; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mouth Neoplasms; Neoplasm Invasiveness; NF-kappa B; Squamous Cell Carcinoma of Head and Neck

2016